1x01 - Value Added Medicines: a patient-centric approach to healthcare
Échec de l'ajout au panier.
Échec de l'ajout à la liste d'envies.
Échec de la suppression de la liste d’envies.
Échec du suivi du balado
Ne plus suivre le balado a échoué
1x01 - Value Added Medicines: a patient-centric approach to healthcare
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
Welcome to Conversations on EU Pharma!
‘Conversations on EU Pharma’ is the podcast created by Medicines for Europe that explores the off-patent medicines world.
In our very first episode, we will talk about Value Added Medicines (VAMs) to understand what benefits they can deliver to patients and the whole healthcare community.
Our guests will be Monica Fletcher OBE, FERS, FQNI Honorary Research Fellow from the University of Edinburgh and Maja Sercic, Policy & Science manager at Medicines for Europe.
Kate O’Regan, Communications & Stakeholder Relations Senior Manager from Medicines for Europe will be our host.
If this episode piques your curiosity, visit our website for more information on VAMs: https://www.medicinesforeurope.com/value-added-medicines /
To learn more about the benefits of VAMs for patients with respiratory diseases, check Monica Fletcher‘s publications https://www.researchgate.net/profile/Monica-Fletcher and take a look at the Asthma UK Centre for Applied Research: https://www.ed.ac.uk/usher/aukcar and at BREATHE – The Health Data Research Hub for Respiratory Health, https://breathedatahub.com/